Regulatory Sepsis Creatinine French
Steven Cotten, PhD, DABCC, NACB, Assistant Professor Pathology & Director of Chemistry and Toxicology Ohio State University, Wexner Medical Center
Charbel Abou-Diwan, PhD, D(ABCC), F(ACB) Directeur Affaires médicales et scientifiques Nova Biomedical
High Dose Vitamin C Therapy in Critically Ill Patients. False Hyperglycemia Associated with POC Glycemic Management
Alexander H. Flannery, PharmD, BCCCP, BCPS, Assistant Professor, Department of Pharmacy Practice and Science Director, PGY2 Critical Care Residency, University of Kentucky HealthCare and College of Pharmacy
Andrei Malic (PhD) Clinical Communications Director, Medical and Scientific Affairs, Nova Biomedical
The Importance of Measuring Ionized Magnesium in Critically Ill Patients
Evan Ntrivalas, MD, PhD, Director, Medical and Scientific Affairs, Nova Biomedical
Bedside Glucose Monitoring – Is it Safe for Critically Ill Patients?
Andrei Malic, PhD, Director, Medical and Scientific Affairs, Nova Biomedical
The Clinical Impact of Improved Glucose Monitoring in Neonatal Intensive Care Pediatric Setting
Khosrow Adeli, PhD, FCACB, NACB, DABCC, Head and Professor, Clinical Biochemistry, The Hospital for Sick Children, University of Toronto
Lactate Monitoring for Severe Sepsis and Septic Shock: Are All Lactate Measurements the Same?
Nam K. Tran, PhD, MS, FACB, Associate Clinical Professor, Director of Clinical Chemistry and Point-of-Care Testing, Department of Pathology and Laboratory Medicine University of California, Davis
The Confusing Conundrum of Collecting and Measuring Glucose in Neonates
Martha Lyon, PhD, DABCC, FACB, Clinical Biochemist/Clinical, Associate Professor, Royal University Hospital, Saskatoon
New Regulatory and Accreditation Issues that Affect Hospital Glycemic Management Programs
Jeffery A. DuBois, PhD, HCLD/CC (ABB), FACP, VP Medical and Scientific Affairs, Nova Biomedical
Can Point-of-Care Creatinine Testing Reduce Contrast-Induced Acute Kidney Injury (CI-AKI) in STEMI Patients Treated with PPCI?
Thomas Keeble, MBBS, BSc, MRCP, MD, Consultant Cardiologist, Southend Hospital, Essex Cardiothoracic Centre, and Senior Clinical Fellow, Anglia Ruskin University
The Sepsis Epidemic: New Sepsis Definitions and Evidenced-Based Treatment
Ron Daniels, BEM, NHS Consultant in Critical Care and Anaesthesia, Co-Founder and Chief Executive, UK Sepsis Trust and CEO, Global Sepsis Alliance
Clinical Impact of Blood Glucose Monitoring System Accuracy in Critical Care
Nam K. Tran, PhD, MS, FACB, Assistant Clinical Professor, Director of Clinical Chemistry and Point-of-Care Testing, Department of Pathology and Laboratory Medicine, University of California, Davis
Point-of-Care Glucose in Critically Ill Patients– The Importance of Glucose Meter Accuracy
Arthur H. Combs, MD, FCCP, FCCM, President, FutureTech Strategies, Inc., Evan Ntrivalas, MD, PhD, Director, Medical and Scientific Affairs, Nova Biomedical
Glucose Meters and Glycemic Control: Does Meter Error Impact Glycemic Control Outcomes?
Brad S. Karon, MD, PhD, Associate Professor of Laboratory Medicine and Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic